Innovative tumor vaccine company Novavax Biotech has received investment from Future Industry (Wuxi) Angel Fund Partnership (Limited Partnership)

　　On March 28th, Novavax Biologics, an innovative tumor vaccine enterprise, received investment from Future Industry (Wuxi) Angel Fund Partnership (Limited Partnership). The funds will be used to support the clinical advancement of the company's self-developed pipeline and the construction of its innovation platform.

　　Novy Biotech (Wuxi) Co., Ltd., established in 2023, is a biopharmaceutical innovation enterprise specializing in the field of early-stage tumor treatment. Leveraging the jointly established STARi (Super-targeted Activated T-cell Immune Response) nucleic acid drug development platform, the company is dedicated to researching and developing a new generation of therapeutic vaccines for tumors. Currently, the company primarily focuses on unmet clinical needs in niche areas such as cervical precancerous lesions and postoperative recurrence of liver cancer, with multiple first-in-class new drugs already entering the clinical development phase.

　　The Wuxi Future Industry Angel Fund, with a total size of RMB 1 billion, adheres to the investment philosophy of "investing in foresight, investing in the future, and investing in talent". It aims to further cultivate and develop forward-looking strategic emerging industries. With the goal of achieving full-chain development in related industries, the fund further optimizes the structure of Wuxi's emerging industries, supplements supporting facilities, focuses on cultivating core technology enterprises in the upstream, midstream, and downstream of the industrial chain, and enhances the value of Wuxi's local industrial chain.

　　Wuxi Venture Capital actively serves the development of Wuxi's "5+X" future industries. It will firmly position itself as a patient capital source for strategic emerging funds, adhere to the principle of "investing early, investing small, and investing in hard technology", accurately explore and cultivate early-stage technological innovation projects, proactively plan for key technologies and core products in key industrial fields, accelerate the race to seize the commanding heights of future industrial development, and promote the integrated development of technological innovation and industrial innovation.